Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Physical external compression refers to the application of a compressive mechanical force onto biological tissues or cells from an external source. In biological systems, such compression can affect cell shape, proliferation, differentiation, apoptosis, gene expression, cytoskeletal dynamics, and mechanotransduction pathways. These changes are mediated by mechanosensitive molecules and signaling pathways (such as integrins, stretch-activated ion channels, and the Rho GTPase family), but the compressive force itself is not a molecule or protein. Physical external compression is employed in clinical settings (e.g., to enhance blood or lymphatic flow), basic cell biology experiments, and is relevant in disease contexts such as cancer, wound healing, and edema. It can have both beneficial and deleterious biological consequences depending on magnitude, duration, and tissue type[1][2][3][4][5][6]. Physical external compression is not a canonical drug target, enzyme, transporter, or receptor, and instead represents a mode of mechanical stimulus with broad biological effects[2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Physical external compression.